Inventor
Sarah S. Bacus
Inventor
Hinsdale, IL, US
Overview
Patents· 16 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
G01Nprimary
G01NInvestigating or analysing materials by determining their chemical or physical properties36%
C07KPeptides15%
A61KPreparations for medical, dental or toiletry purposes10%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms10%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations8%
Y10TTechnical subjects covered by former us classification8%
C12NMicroorganisms or enzymes3%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture3%
E01CConstruction of, or surfaces for, roads, sports grounds, or the like3%
G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data3%
PatentTitleYear
10,851,422Methods of determining an immune response score20209,625,446'Method and quantification assay for determining c-kit/SCF/pAKT status'20179,239,331'Method for predicting the response to HER2-directed therapy'20168,956,822'Method for predicting the response to HER2-directed therapy'20158,946,256'Compositions and methods for treatment of vitiligo'20158,709,738'Methods for predicting cardiac toxicity'20148,623,604'Methods for predicting responsiveness of a cancer cell to an anti-IGFR1 antibody by analysis of mutations in PIK3CA'20148,512,967'Method for predicting the response to HER2-directed therapy'20137,862,995'Methods and materials for predicting responsiveness to treatment with dual tyrosine kinase inhibitor'20117,833,698'Method for determining the response to cancer therapy'20107,771,958'Method for predicting response to epidermal growth factor receptor-directed therapy'20107,419,777'Method and quantification assay for determining c-kit/SCF/pAKT status'20086,962,789'Method for quantitating a protein by image analysis'20055,514,554'Methods and compositions for cancer therapy and for prognosticating responses to cancer therapy'19965,288,477'Method for prognosticating response to cancer therapy'19945,252,487'Method and apparatus for determining the amount of oncogene protein product in a cell sample'1993Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1993–2020Based in Hinsdale, IL, US· patent location history
1994–1996Patents assigned to BECTON DICKINSON CO (2)· patent assignee history
2005–2017Patents assigned to VENTANA MED SYST INC (7)· patent assignee history
2013–2017Patents assigned to BACUS SARAH S (3)· patent assignee history
2013–2016Patents assigned to CELL SIGNALING TECHNOLOGY INC (3)· patent assignee history
2014–2015Patents assigned to BACUS SARAH (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| VENTANA MED SYST INC | 7 | 2005–2017 |
| BACUS SARAH Sself | 3 | 2013–2017 |
| CELL SIGNALING TECHNOLOGY INC | 3 | 2013–2016 |
| BACUS SARAHself | 2 | 2014–2015 |
| BECTON DICKINSON CO | 2 | 1994–1996 |
Locations
| Location | Patents | Span |
|---|---|---|
| Hinsdale, Illinois, US | 16 | 1993–2020 |